SCHEMBL4253324

SCHEMBL4253324

COc1ccc(N(C)c2ccccc2-c2nncc3c(F)cccc23)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CASP1 P29466 1/20 0.41
▸ CASP14 P31944 1/20 0.41
▸ CASP3 P42574 1/20 0.41
▸ CASP2 P42575 1/20 0.41
▸ CASP4 P49662 1/20 0.41
▸ CASP5 P51878 1/20 0.41
▸ CASP7 P55210 1/20 0.41
▸ CASP9 P55211 1/20 0.41
▸ CASP6 P55212 1/20 0.41
▸ CASP8 Q14790 1/20 0.41
▸ CASP12 Q6UXS9 1/20 0.41
▸ CASP10 Q92851 1/20 0.41
▸ NPC1 O15118 3/20 0.40
▸ EGFR P00533 2/20 0.38
▸ PDGFRB P09619 2/20 0.38
▸ KDR P35968 2/20 0.38
▸ MERTK Q12866 3/20 0.36
▸ CES1 P23141 1/20 0.36
▸ BRAF P15056 1/20 0.36
▸ KDM4C Q9H3R0 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3765285 0.80 CASP1 (0.53) CASP1CASP14CASP3CASP2CASP4
SCHEMBL13056982 0.71 CASP1 (0.60) CASP1CASP14CASP3CASP2CASP4
SCHEMBL5553089 0.69 EGFR (0.66) CASP1CASP14CASP3CASP2CASP4
SCHEMBL12048740 0.68 EGFR (0.51) CASP1CASP14CASP3CASP2CASP4
SCHEMBL6778392 0.68 CES1 (0.49) CASP1CASP14CASP3CASP2CASP4
SCHEMBL28563328 0.68 ABL1 (0.50) NPC1EGFRPDGFRBKDRCES1
SCHEMBL13056990 0.68 CASP1 (0.47) CASP1CASP14CASP3CASP2CASP4
SCHEMBL3758758 0.66 CASP1 (0.60) CASP1CASP14CASP3CASP2CASP4
SCHEMBL3765283 0.65 POLB (0.50) EGFRTP53MAPTSMN1; SMN2OXTR
SCHEMBL3765279 0.65 GPR139 (0.36) NPC1BRAFRAB9ATP53MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1833803-A4 PHARMACEUTICAL COMPOUNDS AS ACTIVATORS OF CASPASES AND INDUCERS OF APOPTOSIS AND THE USE THEREOF MYRIAD GENETICS INC (US) 2009-08-05 — — EP disclosed
EP-1833803-A2 PHARMACEUTICAL COMPOUNDS AS ACTIVATORS OF CASPASES AND INDUCERS OF APOPTOSIS AND THE USE THEREOF MYRIAD GENETICS, INC. (US) 2007-09-19 — — EP disclosed
WO-2006074223-A2 PHARMACEUTICAL COMPOUNDS AS ACTIVATORS OF CASPASES AND INDUCERS OF APOPTOSIS AND THE USE THEREOF MYRIAD GENETICS, INC. (US) 2006-07-13 — — WO disclosed
Send feedback